Publications

Journal Article Ahead of print

PubMed: 42663056 DOI: 10.1093/eurheartj/ehag739

Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.

Eur Heart J

Authors: Gaetano M De Ferrari, Robert P Giugliano, Lawrence A Leiter, Jose C Nicolau, Ajay Bhatia, Marcoli Cyrille, Jeong-Gun Park, Julia F Kuder, Sabina A Murphy, Lyrica Liu, Huei Wang, Andrzej Budaj, Jan Cornel, Andrej Džupina, Andrejs Erglis, Henrik K Jensen, Robert Gabor Kiss, Johanna Kuusisto, Jose Lopez-Sendon, Alberto Lorenzatti, Giles Montalescot, Stephen Nicholls, Alexandr Parkhomenko, Axel Sigurdsson, Margus Viigimaa, Gabriel Paiva da Silva Lima, Marc S Sabatine, Erin A Bohula

Affiliations

  • Cardiology Division, Department of Medical Sciences, University of Torino and Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino Italy.
  • TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Instituto do Coracao, Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Universidade de São Paulo, São Paulo.
  • Amgen, Thousand Oaks, CA.
  • Department of Cardiology, Centre of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland.
  • Department of Cardiology, Noordwest Ziekenhuisgroep, Alkmaar and Radboudumc, Nijmegen, the Netherlands.
  • Department of Angiology, Comenius University and National Institute of Cardiovascular Diseases, Bratislava, Slovakia.
  • Pauls Stradins Clinical University Hospital, University of Latvia, Riga, Latvia.
  • Department of Cardiology, Aarhus University Hospital and Department of Clinical Medicine, Health, Aarhus University, Aarhus N, Denmark.
  • Cardiovascular Center, Semmelweis University, Budapest, Hungary.
  • Centre for Medicine and Clinical Research, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  • Idipaz Research Institute. Cardiology Hospital La Paz, Universidad Autonoma de Madrid. Spain.
  • DAMIC Medical Institute & Rusculleda Foundation for Research, Cordoba, Argentina.
  • ACTION Study Group, Sorbonne University, AP-HP, Hôpital Pitié-Salpétrière, Paris, France.
  • Victorian Heart Institute, Monash University, Melbourne, Victoria, Australia.
  • National Scientific Center named after M.D.Strazhesko, Kyiv, Ukraine.
  • University of Iceland, Reykjavik, Iceland.
  • North Estonia Medical Centre, Tallinn University of Technology, Tallinn, Estonia.

MeSH

Myocardial Infarction, Cardiology